Description

Pyrimido[2,1-F]Purine-2,4,8(1H,3H,9H)-Trione, 7-[2-(Acetyloxy)Ethyl]-6-Hydroxy-1,3-Dimethyl-9-(Phenylmethyl)- is a complex heterocyclic organic compound with a purine-dione core structure, serving as a sophisticated chemical building block. Its value lies in its functionalized molecular architecture, which makes it a critical intermediate for advanced research and synthesis in life sciences. This compound is primarily needed by pharmaceutical R&D teams and fine chemical manufacturers focused on developing novel therapeutic agents and high-value specialty chemicals.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of novel purine-based drug candidates, including potential kinase inhibitors and antiviral agents.
• Biochemical Research: Used as a reference standard or a core scaffold in medicinal chemistry for structure-activity relationship (SAR) studies.
• Fine Chemical Synthesis: Serves as a versatile building block for creating complex molecules in custom synthesis and process development.
• Academic Research: Employed in university and institutional labs for investigating heterocyclic chemistry and developing new synthetic methodologies.
• Agrochemical Development: Potential intermediate for creating new active ingredients with specific biological activity.

Basic Information

Product Name	Pyrimido[2,1-F]Purine-2,4,8(1H,3H,9H)-Trione, 7-[2-(Acetyloxy)Ethyl]-6-Hydroxy-1,3-Dimethyl-9-(Phenylmethyl)-
CAS No.	91285-17-5
Molecular Formula	C21H22N4O6
Molecular Weight	426.43 g/mol
Synonyms	7-(2-Acetoxyethyl)-6-hydroxy-1,3-dimethyl-9-benzylpyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-trione; 9-Benzyl-7-(2-hydroxyethoxy)-1,3-dimethyl-1H,3H,9H-pyrimido[2,1-f]purine-2,4,8-trione acetate; 7-[2-(Acetyloxy)ethyl]-6-hydroxy-1,3-dimethyl-9-(phenylmethyl)-pyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-trione; 1,3-Dimethyl-9-benzyl-7-(2-acetoxyethyl)-6-hydroxypyrimido[2,1-f]purine-2,4,8-trione; 91285-17-5; 7-(2-Acetoxyethyl)-1,3-dimethyl-9-benzyl-6-hydroxypyrimido[2,1-f]purine-2,4,8-trione
EINECS	Contact for details

Quality Control

Our Pyrimido[2,1-F]Purine-2,4,8(1H,3H,9H)-Trione intermediate is produced under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the high standards required for pharmaceutical research and fine chemical synthesis. Certificates of Analysis (COA) detailing purity (typically by HPLC), identification, and impurity profiles are available upon request. We adhere to cGMP principles where applicable to support our global clientele.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The compound may be hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.